Major Lectureships and Seminars
- Advances in Evidence-based Care in Pediatric Hypertension. American Society of Nephrology annual meeting, New Orleans, LA, November 2017.
Professional Affiliations/Society Memberships
- American Society of Pediatric Nephrology
- International Pediatric Hypertension Association
- International Pediatric Nephrology Association
Yosuke Miyashita’s research interests focuses on pediatric hypertension and Shiga toxin producing Escherichia coli, and atypical hemolytic uremic syndrome. He is the representative for UPMC Children’s Hospital of Pittsburgh in the Midwest Pediatric Nephrology Consortium (MWPNC). He participates in multicenter clinical trials with this consortium, especially in the field of pediatric hypertension and the use of 24-hour ambulatory blood pressure monitoring. His most recent efforts are aimed at formulating an evidence-based practice guideline for white coat hypertension in children and adolescents. For this effort, he recently completed and published a survey study of pediatric nephrologists in the MWPNC centers on white coat hypertension. He investigated the changes of 24-hour ambulatory blood pressure monitoring results over time for children and adolescents who are followed for blood pressure concerns but not on antihypertensive medication. These were pilot studies for an eventual multi-center retrospective study to investigate the same issue in the larger MWPNC cohort, which is currently ongoing. Lastly, he serves as faculty facilitator for trainees participating in various MWPNC research projects.